
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $249.6M | $504.3M | $865.8M | $826.8M | $859.7M | |
Revenue Growth (YoY) | -16.23% | 102.07% | 71.68% | -4.5% | 3.99% | |
Cost of Revenues | $120.3M | $135.5M | $177.4M | $196.5M | $275.3M | |
Gross Profit | $129.2M | $368.8M | $688.3M | $630.3M | $584.5M | |
Gross Profit Margin | 51.78% | 73.12% | 79.51% | 76.23% | 67.98% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.2M | $7.8M | $8.5M | $10.6M | $18.6M | |
Other Inc / (Exp) | -$140.1M | -$69.3M | -$18.1M | -$25.5M | $11.4M | |
Operating Expenses | $7.1M | $7.2M | $7.8M | $10.1M | $18.1M | |
Operating Income | $122.1M | $361.6M | $680.5M | $620.2M | $566.4M | |
Net Interest Expenses | $33M | $34M | $40M | $47.4M | $73.8M | |
EBT. Incl. Unusual Items | -$50.9M | $258.2M | $622.4M | $547.3M | $503.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $142.5M | $1.5M | -$32.7M | $46M | -$99.7M | |
Net Income to Company | -$193.4M | $256.7M | $655M | $501.3M | $603.6M | |
Minority Interest in Earnings | $1.1M | -$198.7M | -$503.3M | -$301.3M | -$244.4M | |
Net Income to Common Excl Extra Items | -$192.3M | $57.9M | $151.7M | $200.1M | $359.2M | |
Basic EPS (Cont. Ops) | -$2.84 | $0.85 | $2.00 | $2.69 | $3.82 | |
Diluted EPS (Cont. Ops) | -$2.84 | $0.85 | $2.00 | $2.69 | $3.82 | |
Weighted Average Basic Share | $67.7M | $68.3M | $75.6M | $74.2M | $93.9M | |
Weighted Average Diluted Share | $67.7M | $68.4M | $75.7M | $74.2M | $93.9M | |
EBITDA | $82.6M | $395.2M | $783.4M | $740.8M | $792.2M | |
EBIT | -$17.9M | $292.2M | $662.3M | $594.7M | $577.8M | |
Revenue (Reported) | $249.6M | $504.3M | $865.8M | $826.8M | $859.7M | |
Operating Income (Reported) | $122.1M | $361.6M | $680.5M | $620.2M | $566.4M | |
Operating Income (Adjusted) | -$17.9M | $292.2M | $662.3M | $594.7M | $577.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $96.8M | $201.8M | $168.6M | $205M | $245M | |
Revenue Growth (YoY) | 23.44% | 108.36% | -16.46% | 21.62% | 19.51% | |
Cost of Revenues | $31.5M | $41.3M | $43.9M | $61M | $84M | |
Gross Profit | $65.3M | $160.5M | $124.7M | $144M | $161M | |
Gross Profit Margin | 67.44% | 79.54% | 73.97% | 70.24% | 65.71% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.2M | $2M | $2.8M | $5M | $6M | |
Other Inc / (Exp) | -$31.5M | -$18.4M | -$15M | -$7M | $32M | |
Operating Expenses | $2.1M | $1.8M | $2.4M | $5M | $6M | |
Operating Income | $63.2M | $158.7M | $122.3M | $139M | $155M | |
Net Interest Expenses | $7.9M | $9.6M | $9.7M | $20M | $13M | |
EBT. Incl. Unusual Items | $23.9M | $130.7M | $97.7M | $112M | $174M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $35K | $2.6M | $9.4M | $13M | $21M | |
Net Income to Company | $23.9M | $128M | $88.3M | $99M | $153M | |
Minority Interest in Earnings | -$26.9M | -$111.4M | -$54.3M | -$56M | -$78M | |
Net Income to Common Excl Extra Items | -$3M | $16.6M | $34M | $43M | $75M | |
Basic EPS (Cont. Ops) | -$0.05 | $0.22 | $0.47 | $0.49 | $0.62 | |
Diluted EPS (Cont. Ops) | -$0.05 | $0.22 | $0.47 | $0.49 | $0.62 | |
Weighted Average Basic Share | $65.4M | $77.1M | $72.7M | $87.5M | $120.9M | |
Weighted Average Diluted Share | $65.4M | $77.2M | $72.8M | $87.6M | $121M | |
EBITDA | $56.6M | $167.7M | $138.3M | $179M | $254M | |
EBIT | $31.8M | $140.3M | $107.4M | $132M | $187M | |
Revenue (Reported) | $96.8M | $201.8M | $168.6M | $205M | $245M | |
Operating Income (Reported) | $63.2M | $158.7M | $122.3M | $139M | $155M | |
Operating Income (Adjusted) | $31.8M | $140.3M | $107.4M | $132M | $187M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $268M | $609.2M | $832.6M | $863.2M | $899.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $121.1M | $145.3M | $180M | $213.6M | $298M | |
Gross Profit | $146.9M | $463.9M | $652.5M | $649.6M | $601.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $7.7M | $7.5M | $9.4M | $12.8M | $19.6M | |
Other Inc / (Exp) | -$153.9M | -$56.2M | -$14.7M | -$17.4M | $50.9M | |
Operating Expenses | $6.8M | $6.9M | $8.4M | $12.7M | $19.1M | |
Operating Income | $140.1M | $457M | $644.1M | $636.9M | $582.5M | |
Net Interest Expenses | $31.9M | $35.8M | $40M | $57.8M | $67.5M | |
EBT. Incl. Unusual Items | -$45.7M | $365M | $589.4M | $561.6M | $565.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $35K | $4.1M | -$25.9M | $49.5M | -$91.2M | |
Net Income to Company | -$45.7M | $360.9M | $615.2M | $512.1M | $657.6M | |
Minority Interest in Earnings | -$7.5M | -$283.3M | -$446.2M | -$303M | -$266.2M | |
Net Income to Common Excl Extra Items | -$53.2M | $77.6M | $169M | $209.1M | $390.9M | |
Basic EPS (Cont. Ops) | -$0.79 | $1.05 | $2.26 | $2.72 | $3.80 | |
Diluted EPS (Cont. Ops) | -$0.79 | $1.05 | $2.26 | $2.72 | $3.80 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $87M | $506.3M | $754M | $781.6M | $867.8M | |
EBIT | -$13.8M | $400.8M | $629.4M | $619.5M | $633.3M | |
Revenue (Reported) | $268M | $609.2M | $832.6M | $863.2M | $899.5M | |
Operating Income (Reported) | $140.1M | $457M | $644.1M | $636.9M | $582.5M | |
Operating Income (Adjusted) | -$13.8M | $400.8M | $629.4M | $619.5M | $633.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $96.8M | $201.8M | $168.6M | $205M | $245M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $31.5M | $41.3M | $43.9M | $61M | $84M | |
Gross Profit | $65.3M | $160.5M | $124.7M | $144M | $161M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.2M | $2M | $2.8M | $5M | $6M | |
Other Inc / (Exp) | -$31.5M | -$18.4M | -$15M | -$7M | $32M | |
Operating Expenses | $2.1M | $1.8M | $2.4M | $5M | $6M | |
Operating Income | $63.2M | $158.7M | $122.3M | $139M | $155M | |
Net Interest Expenses | $7.9M | $9.6M | $9.7M | $20M | $13M | |
EBT. Incl. Unusual Items | $23.9M | $130.7M | $97.7M | $112M | $174M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $35K | $2.6M | $9.4M | $13M | $21M | |
Net Income to Company | $23.9M | $128M | $88.3M | $99M | $153M | |
Minority Interest in Earnings | -$26.9M | -$111.4M | -$54.3M | -$56M | -$78M | |
Net Income to Common Excl Extra Items | -$3M | $16.6M | $34M | $43M | $75M | |
Basic EPS (Cont. Ops) | -$0.05 | $0.22 | $0.47 | $0.49 | $0.62 | |
Diluted EPS (Cont. Ops) | -$0.05 | $0.22 | $0.47 | $0.49 | $0.62 | |
Weighted Average Basic Share | $65.4M | $77.1M | $72.7M | $87.5M | $120.9M | |
Weighted Average Diluted Share | $65.4M | $77.2M | $72.8M | $87.6M | $121M | |
EBITDA | $56.6M | $167.7M | $138.3M | $179M | $254M | |
EBIT | $31.8M | $140.3M | $107.4M | $132M | $187M | |
Revenue (Reported) | $96.8M | $201.8M | $168.6M | $205M | $245M | |
Operating Income (Reported) | $63.2M | $158.7M | $122.3M | $139M | $155M | |
Operating Income (Adjusted) | $31.8M | $140.3M | $107.4M | $132M | $187M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $19.1M | $39.4M | $18.2M | $25.9M | $26.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $34.2M | $70.7M | $87.9M | $112M | $180.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $665K | $989K | $2.5M | $4.5M | $11.1M | |
Total Current Assets | $54M | $111.1M | $118.6M | $143.5M | $238M | |
Property Plant And Equipment | $2.4B | $2.9B | $2.8B | $3.8B | $4.6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.3M | $2.8M | $1.4M | $5.5M | $8.2M | |
Total Assets | $2.5B | $3B | $2.9B | $4B | $5.1B | |
Accounts Payable | $43K | $69K | $1.1M | $19K | $85K | |
Accrued Expenses | $4.4M | $5.4M | $5.4M | $12.4M | $21.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $26.6M | $3.4M | -- | $3M | $2.3M | |
Total Current Liabilities | $44.9M | $24.5M | $21.9M | $33.3M | $48.7M | |
Long-Term Debt | $555.6M | $776.7M | $576.9M | $1.1B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $600.5M | $801.2M | $598.8M | $1.1B | $1.2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $635.3M | $814.8M | -- | $1B | $1.7B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.2B | $1.4B | $1.6B | $1.8B | $2.2B | |
Total Equity | $1.9B | $2.2B | $2.3B | $2.9B | $3.9B | |
Total Liabilities and Equity | $2.5B | $3B | $2.9B | $4B | $5.1B | |
Cash and Short Terms | $19.1M | $39.4M | $18.2M | $25.9M | $26.9M | |
Total Debt | $555.6M | $776.7M | $576.9M | $1.1B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $11.7M | $33.1M | $9.1M | $20M | $560M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $47.3M | $102.7M | $119.4M | $165.1M | $187M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $505K | $944K | $3.4M | $4.7M | $12M | |
Total Current Assets | $59.5M | $136.7M | $133.3M | $189.8M | $792M | |
Property Plant And Equipment | $2.4B | $2.9B | $2.8B | $3.7B | $5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2M | $1.9M | $170K | $5.2M | $230M | |
Total Assets | $2.4B | $3B | $3B | $4B | $6.2B | |
Accounts Payable | $21K | $14K | $436K | $17K | $2M | |
Accrued Expenses | $11M | $13.7M | $11.9M | $25.8M | $57M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $43.2M | $13.2M | $2.1M | $8.5M | $5M | |
Total Current Liabilities | $62.9M | $37.1M | $29.8M | $54.9M | $91M | |
Long-Term Debt | $528.9M | $721M | $695.2M | $1.1B | $822M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $591.8M | $758.1M | $727.3M | $1.1B | $915M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.2B | $1.5B | $1.6B | $1.8B | $2.6B | |
Total Equity | $1.9B | $2.2B | $2.3B | $2.9B | $5.3B | |
Total Liabilities and Equity | $2.4B | $3B | $3B | $4B | $6.2B | |
Cash and Short Terms | $11.7M | $33.1M | $9.1M | $20M | $560M | |
Total Debt | $528.9M | $721M | $695.2M | $1.1B | $822M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$193.4M | $256.7M | $655M | $501.3M | $603.6M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $34.5M | -$36.5M | -$17.2M | -$24.4M | -$40.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $196.6M | $307.1M | $699.8M | $638.2M | $619.6M | |
Capital Expenditures | $65.7M | $281.2M | $64.1M | $908.4M | $696.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$16.3M | -$281.2M | $47.6M | -$908.4M | -$608.6M | |
Dividends Paid (Ex Special Dividend) | -$108M | -$176.6M | -$416.9M | -$324.8M | -$473.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $104M | $330M | $272M | $973M | $842M | |
Long-Term Debt Repaid | -$136.2M | -$110M | -$473M | -$462M | -$844M | |
Repurchase of Common Stock | -$24M | -$46M | -$150.6M | -$95.2M | -- | |
Other Financing Activities | -$575K | -$3M | -$142K | -$13.2M | -$10.3M | |
Cash From Financing | -$164.8M | -$5.6M | -$768.6M | $277.9M | -$10.1M | |
Beginning Cash (CF) | $3.6M | $19.1M | $39.4M | $18.2M | $25.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $15.5M | $20.3M | -$21.3M | $7.7M | $982K | |
Ending Cash (CF) | $19.1M | $39.4M | $18.2M | $25.9M | $26.9M | |
Levered Free Cash Flow | $130.9M | $25.9M | $635.7M | -$270.2M | -$76.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $42.4M | $171.6M | $79.9M | $122.8M | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $1.6M | -$30.3M | $34.2M | -$1.9M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $75M | $163.2M | $145.4M | $143.7M | -- | |
Capital Expenditures | $745K | -- | $7.9M | $8.2M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$745K | -$759K | -$7.9M | $81.5M | -- | |
Dividends Paid (Ex Special Dividend) | -$38.9M | -$115.2M | -$61.9M | -$113.8M | -- | |
Special Dividend Paid | -- | -- | $80K | $320K | -- | |
Long-Term Debt Issued | $25M | $100M | $73M | $5M | -- | |
Long-Term Debt Repaid | -$20M | -$147M | -$119M | -$101M | -- | |
Repurchase of Common Stock | -$6.8M | -$28.9M | -$24.5M | -- | -- | |
Other Financing Activities | -$2.9M | -$63K | -$1.2M | -$63K | -- | |
Cash From Financing | -$43.6M | -$191.2M | -$133.6M | -$209.9M | -- | |
Beginning Cash (CF) | $11.7M | $33.1M | $9.1M | $20M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $30.7M | -$28.8M | $4M | $15.3M | -- | |
Ending Cash (CF) | $42.4M | $4.3M | $13.1M | $35.2M | -- | |
Levered Free Cash Flow | $74.3M | $163.2M | $137.6M | $135.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$45.7M | $360.9M | $615.2M | $512.1M | $657.6M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$9.4M | -$55.4M | -$16.7M | -$46M | $5.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $155.1M | $388.3M | $671.2M | $645.9M | $705.6M | |
Capital Expenditures | $1.1M | $281.1M | $180.7M | $812.8M | $1.2B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $48.3M | -$249.1M | -$101M | -$811.8M | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$58.5M | -$233.6M | -$422.7M | -$351.1M | -$506.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $12M | $374M | $346M | $945M | $1B | |
Long-Term Debt Repaid | -$148.2M | -$183M | -$373M | -$542M | -$1.3B | |
Repurchase of Common Stock | -$37.1M | -$72.2M | -$144.4M | -$62.2M | -- | |
Other Financing Activities | -$196K | -$3M | -$142K | -- | -$19.3M | |
Cash From Financing | -$231.9M | -$117.8M | -$594.2M | $176.6M | $908.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$28.5M | $21.3M | -$24M | $10.8M | $540M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $154M | $107.2M | $490.5M | -$166.8M | -$455.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $66.2M | $299.7M | $168.2M | $221.8M | $153M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$11.5M | -$62.3M | $2.8M | -$54.9M | -$7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $129.7M | $299M | $252.7M | $258.7M | $201M | |
Capital Expenditures | $819K | -- | $124.5M | $29.2M | $486M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$819K | $31.2M | -$124.5M | $61.5M | -$486M | |
Dividends Paid (Ex Special Dividend) | -$60.8M | -$194.1M | -$146.6M | -$224.8M | -$144M | |
Special Dividend Paid | -- | -- | $320K | $610K | -- | |
Long-Term Debt Issued | $25M | $144M | $191M | $95M | $295M | |
Long-Term Debt Repaid | -$47M | -$247M | -$119M | -$181M | -$556M | |
Repurchase of Common Stock | -$19.8M | -$68.2M | -$57.5M | -- | -- | |
Other Financing Activities | -$2.9M | -$83K | -$1.2M | -$63K | -$9M | |
Cash From Financing | -$105.6M | -$365.4M | -$133.3M | -$310.9M | $818M | |
Beginning Cash (CF) | $30.8M | $72.5M | $27.3M | $46M | $27M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $23.3M | -$35.1M | -$5.1M | $9.3M | $533M | |
Ending Cash (CF) | $54.1M | $37.4M | $22.2M | $55.2M | $560M | |
Levered Free Cash Flow | $128.9M | $299M | $128.2M | $229.6M | -$285M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.